NEOGENOMICS INC
NEO·64049M209·US·Common Stock·Healthcare - Diagnostics & Research-13D/G
NEO (NEOGENOMICS INC) is held by 136 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($304.5M), FIRST TRUST ADVISORS LP ($147.6M), VANGUARD PORTFOLIO MANAGEMENT LLC ($117.6M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 92 funds bought NEO.
Who's Trading
Source dates: Price Sep 18, 2026 · Insiders Sep 3, 2026 · Activists Aug 14, 2026 · Congress Sep 10, 2026
Top Holders
Showing 1-20 of 155
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer